The US Centers for Medicare & Medicaid Services’ (CMS) failure to provide payment for invasive FFR has resulted in worse and inequitable Medicare beneficiary healthcare.

Main Article Content

Gerald Dorros, M.D., FACC

Abstract

The unintended consequences of the US Centers for Medicare & Medicaid Services’ (CMS) decision not to pay for invasive diagnostic FFR (Fractional Flow Reserve) has precluded its routine diagnostic use in hundreds of thousands of Medicare Beneficiaries, who suffered inappropriate coronary stent procedures (PCI) that worsened Medicare beneficiaries’ clinical outcomes: 20% of PCI patients have no or uncertain clinical indications but are operated upon, nevertheless, and 33% of potential PCI stenoses are non-ischemic and require no PCI. These unnecessary PCIs, often confounded by aging’s anatomical and comorbid complexities, result in preventable complications, repeat procedures, worse clinical outcomes, unwarranted deaths, and an avoidable $1 billion annual expenditure. The best coronary artery disease (CAD) patient care requires astute clinical assessment coupled with diagnostic physiologic ischemic lesion categorization, which directly links lesion treatment to patient management. CMS’ unrealistic expectation that their bundled payment to a single healthcare provider payment would motivate providers to maximize their profits through efficiently coordinated and improved care was naive; this foolish policy of eschewing invasive FFR payment and expecting providers to absorb the FFR pressure wire’s cost, has inflicted potential irreparable harm on all Medicare beneficiaries. CMS has forsaken its mission to attain the “highest level of health for all people, where everyone has a fair and just opportunity to attain their optimal health regardless of race, ethnicity, disability, sexual orientation, gender identity, socioeconomic status, geography, preferred language, or other factors that affect access to care and health outcomes”.

Keywords: Fractional Flow Reserve (FFR), Fractional Flow Reserve (FFR) reimbursement policy, FFR reimbursement policy, Reimbursement Policy, Medicare beneficiary healthcare, healthcare, US Centers for Medicare & Medicaid Services’ (CMS), CMS, Policy Article

Article Details

How to Cite
DORROS, Gerald. The US Centers for Medicare & Medicaid Services’ (CMS) failure to provide payment for invasive FFR has resulted in worse and inequitable Medicare beneficiary healthcare.. Medical Research Archives, [S.l.], v. 11, n. 2, feb. 2023. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3525>. Date accessed: 29 mar. 2024. doi: https://doi.org/10.18103/mra.v11i2.3525.
Section
Review Articles

References

1. Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2022 Jan 18; 79(2).
2. Matlock DD, Groeneveld PW, Sidney S, et al. Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA. 2013 Jul 10;310(2):155-62.
3. Baker LC, Bundorf MK, Devlin AM, Kessler DP. Medicare Advantage Plans Pay Hospitals Less Than Traditional Medicare Pays. Health Aff (Millwood). 2016 Aug 1;35(8):1444-51.
4. Hodgson JMcB. What Part of the FFR Link Don’t We Understand? J Am Coll Cardiol. 2014 Oct, 64 (16) 1655–1657.
5. Jerry H. Gurwitz, MD; Robert J. Goldberg, PhD. Age-Based Exclusions from Cardiovascular Clinical Trials: Implications for Elderly Individuals (and for All of Us) Comment on “The Persistent Exclusion of Older Patients from Ongoing Clinical Trials Regarding Heart Failure”. Arch Intern Med. 2011;171(6):557-558.
6. Chan PS, Patel MR, Klein LW, et al. Appropriateness of percutaneous coronary intervention. JAMA. 2011 Jul 6;306(1):53-61.
7. Bradley SM, Chan PS, Spertus JA, et al. Procedural Outcomes: Insights from the NCDR® Hospital Percutaneous Coronary Intervention Appropriateness and In-Hospital Procedural Outcomes. Circ Cardiovasc Qual Outcomes. 2012 May; 5(3): 290–297.
8. Chan PS, Rao SV, Bhatt DL, et al. Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions. J Am Coll Cardiol. 2013 Dec 17;62(24):2274-81.
9. Bradley SM, Spertus JA, Kennedy KF, et al. Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness: insights from the National Cardiovascular Data Registry. JAMA Intern Med. 2014 Oct;174(10):1630-9.
10. Thomas MP, Parzynski CS, Curtis JP, et al. Percutaneous Coronary Intervention Utilization and Appropriateness across the United States. PLoS One. 2015 Sep 17;10(9): e0138251.
11. Desai NR, Bradley SM, Parzynski CS, et al. Appropriate Use Criteria for Coronary Revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA, 314 (2015), pp. 2045-2053
12. Dehmer GJ, Weaver D, Roe MT, et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol. 2012 Nov 13;60(20):2017-31
13. Fanaroff AC, Zakroysky P, Wojdyla D, et al. Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention. Circulation. 2019 Jan 22;139(4):458-472.
14. De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012 Sep 13;367(11):991-1001.
15. Bech GJW, De Bruyne B, Pijls NHJ, et al. Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis : A Randomized Trial. Circulation. 2001;103(24):2928-2934.
16. Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol. 2010 Jul 13;56(3):177-84.
17. Xaplanteris P, Fournier S, Pijls NHJ, et al. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. N Engl J Med. 2018 Jul 19;379(3):250-259
18. Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol. 2007 May 29;49(21):2105-11.
19. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009 Jan 15;360(3):213-24.
20. Nallamothu BK, Spertus JA, Lansky AJ, et al. Comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: the Assessing Angiography (A2) project. Circulation. 2013;127(17):1793-1800
21. Zhang YH, Li J, Flammer AJ, et al. Long-term outcomes after fractional flow reserve-guided percutaneous coronary intervention in patients with severe coronary stenosis. Geriatr Cardiol. 2019 Apr;16(4):329-337.
22. Enezate T, Omran J, Al-Dadah AS, et al. Fractional flow reserve versus angiography guided percutaneous coronary intervention: An updated systematic review. Catheter Cardiovasc Interv. 2018 Jul;92(1):18-27.
23. Völz S, Dworeck C, Redfors B, et al. Survival of Patients with Angina Pectoris Undergoing Percutaneous Coronary Intervention with Intracoronary Pressure Wire Guidance. J Am Coll Cardiol. 2020 Jun 9;75(22):2785-2799.
24. Sawant AC, Bhardwaj A, Banerjee K, et al. Fractional flow reserve guided percutaneous coronary intervention results in reduced ischemic myocardium and improved outcomes. Catheter Cardiovasc Interv. 2018 Oct 1;92(4):692-700.
25. Lim HS, Tonino PA, De Bruyne B, et al. The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy. Int J Cardiol. 2014 Nov 15;177(1):66-70.
26. Fanaroff AC, Zakroysky P, Dai D, et al. Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States. J Am Coll Cardiol. 2017 Jun 20;69(24):2913-2924.
27. Hannawi B, Lam WW, Wang S, Younis GA. Current use of fractional flow reserve: a nationwide survey. Texas Heart Institute Journal. 2014 Dec; 41(6):579–84.
28. Van Belle E, Baptista SB, Raposo L, et al. Impact of Routine Fractional Flow Reserve on Management Decision and 1-Year Clinical Outcome of Patients with Acute Coronary Syndromes: PRIME-FFR (Insights from the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] Integrated Multicenter Registries - Implementation of FFR [Fractional Flow Reserve] in Routine Practice). Circ Cardiovasc Interv. 2017 Jun;10(6): e004296.
29. Andell P, Berntorp K, Christiansen EH, et al. Reclassification of Treatment Strategy with Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial. JACC Cardiovasc Interv. 2018 Oct 22;11(20):2084-2094.
30. Van Belle E, Gil R, Klauss V, Balghith M, et al. Impact of Routine Invasive Physiology at Time of Angiography in Patients with Multivessel Coronary Artery Disease on Reclassification of Revascularization Strategy: Results from the DEFINE REAL Study. JACC Cardiovasc Interv. 2018 Feb 26;11(4):354-365.
31. Patel MR, Jeremias A, Maehara A, et al. 1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI: DEFINE PCI Trial. JACC Cardiovasc Interv. 2022 Jan 10;15(1):52-61.
32. Kasula S, Agarwal SK, Hacioglu Y, et al. Clinical and prognostic value of post stenting fractional flow reserve in acute coronary syndromes. Heart. 2016 Dec 15;102(24):1988-199
33. Kobayashi Y, Fearon WF. Predicting Outcomes After Percutaneous Coronary Intervention Using Relative Change in Fractional Flow Reserve. JACC: Cardiovascular Interventions. October 2018, Pages 2110-2112
34. Agarwal SK, Kasula S, Hacioglu Y, et al. Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes. JACC Cardiovasc Interv. 2016 May 23;9(10):1022-31.
35. Shin D, Lee SH, Lee JM, et al. Prognostic Implications of Post-Intervention Resting Pd/Pa and Fractional Flow Reserve in Patients with Stent Implantation. JACC Cardiovasc Interv. 2020 Aug 24;13(16):1920-1933.
36. Jeremias A, Davies JE, Maehara A, et al. Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI Study. JACC Cardiovasc Interv. 2019 Oct 28;12(20):1991-2001.
37. Agarwal SK, Kasula S, Hacioglu Y, et al. Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes. JACC Cardiovasc Interv. 2016 May 23;9(10):1022-31.
38. Hwang D, Koo BK, Zhang J, et al. Prognostic Implications of Fractional Flow Reserve After Coronary Stenting: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 Sep 1;5(9): e2232842.
39. Hakeem A, Uretsky BF. Role of Postintervention Fractional Flow Reserve to Improve Procedural and Clinical Outcomes. Circulation. 2019 Jan 29;139(5):694-706.
40. Lee JM, Hwang D, Choi KH, et al. Prognostic Implications of Relative Increase and Final Fractional Flow Reserve in Patients with Stent Implantation. JACC Cardiovasc Interv.2018 Oct 22;11(20):2099-2109. Prognostic
41. Hakeem A, Ghosh B, Shah K, et al. Incremental Prognostic Value of Post-Intervention Pd/Pa in Patients Undergoing Ischemia-Driven Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2019 Oct 28;12(20):2002-201
42. Vandermolen S, Abbott J, De Silva K. What’s Age Got to do with it? A Review of Contemporary Revascularization in the Elderly. Curr Cardiol Rev. 2015 Aug; 11(3): 199–208.
43. Batchelor WB, Anstrom KJ, Muhlbaier LH, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol. 2000 Sep;36(3):723-30.
44. Rajani R, Lindblom M, Dixon G, et al. Evolving trends in percutaneous coronary intervention. Br J Cardiol. 2011; 18:73–76.
45. Numasawa Y, Inohara T, Ishii H, et al. Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, including 10 628 Nonagenarians: Insights from a Japanese Nationwide Registry (J-PCI Registry). J Am Heart Assoc. 2019 Mar 5;8(5): e011183.
46. Damluji AA, Huang J, Bandeen-Roche K, et al. Frailty Among Older Adults with Acute Myocardial Infarction and Outcomes from Percutaneous Coronary Interventions. J Am Heart Assoc. 2019 Sep 3;8(17): e013686. t.
47. Chen X, Salim Barywani SB, Sigurjonsdottir R, Fu M. Elderly patients with acute coronary syndrome. BMC Geriatr. 2018; 18: 137.
48. Damluji AA, Bandeen-Roche K, Berkower C, et al. Percutaneous Coronary Intervention in Older Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock. J Am Coll Cardiol. 2019 Apr 23;73(15):1890-1900.
49. Langabeer JR, Henry TD, Kereiakes DJ, et al. Growth in percutaneous coronary intervention capacity relative to population and disease prevalence. J Am Heart Assoc. 2013 Oct 28;2(6).